An explanation for the "lag phenomenon" in drug-free control of hypertension by dietary salt restriction in patients with chronic kidney disease on hemodialysis

Clinical Nephrology

Volumn 66, Issue 1, 2006, Pages 1-2

  Shaldon, Stanley ^a  

^a NONE   (Monaco)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM;

ANURIA; BLOOD PRESSURE REGULATION; BLOOD VESSEL WALL; CHRONIC KIDNEY FAILURE; DIALYSATE; DISEASE CONTROL; DRY WEIGHT; EDITORIAL; HEART OUTPUT; HEMODIALYSIS; HEMODYNAMICS; HUMAN; HYPERTENSION; INFLAMMATION; ORTHOSTATIC HYPOTENSION; SODIUM RESTRICTION; VASCULAR RESISTANCE;

EID: 33745899588     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp66001     Document Type: Editorial

References (15)

1. Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis. 1998; 32: 720-724.
2. Comty C, Rottka H, Shaldon S. Blood pressure control in patients with end-stage renal failure treated by intermittent hemodialysis. Proc Eur Dial Transplant Assoc. 1964; 1: 209-213.
3. Fujiwara N, Osanai T, Kamada T et al. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Circulation. 2000; 101: 856-861.
4. Heer M, Baisch FM, Kropp J et al. High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Ren Physiol. 2000; 278: F585-F595.
5. Kempner W. Treatment of kidney disease and hypertensive vascular disease with rice diet. N C Med J. 1944; 5: 125-133.
6. Khosla UM, Johnson RJ. Hypertension in the hemodialysis patients and the "lag phenomenon: insights into pathophysiology and clinical management. Am J Kidney Dis. 2004; 43: 739-751.
7. Luik AJ, Charra B, Katzarski K et al. Blood pressure control and hemodynamic changes in patients on long-time dialysis treatment. Blood Purif 1988; 16: 197-209.
8. MacAllister RJ, Rambausek MH, Vallance P et al. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant. 1996; 11: 2449-2452.
9. Ritz E. Where does some of the ingested sodium chloride hide without exerting osmotic pressure? J Am Soc Nephrol. 2006; 17: 3-11.
10. Sanders PW. Salt intake, endothelial cell signaling and progression of kidney disease. Hypertension. 2004; 43: 142-146.
11. Scribner BH, Buri R, Caner JEZ, Hegstrom R, Burnell JM. The treatment of chrome uremia by means of intermittent hemodialysis: a preliminary report. Trans Am Soc Artif Int Organs. 1960; 6: 114-122.
12. Shaldon S. Dietary salt restriction and drug-free treatment of hypertension in ESRD patients: a largely abandoned therapy. Nephrol Dial Transplant. 2002; 17: 1163-1165.
13. Shaldon S. What clinical insights from the early days of dialysis are being overlooked today? Semin Dial. 2005; 18: 18-19.
14. Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA. 1995; 92: 12230-12234.
15. + storage in the skin. Am J Physiol Heart Circ Physiol. 2004; 287: H203-H208.